FDA Proposes to Revoke Health Claim Regulation on Folic Acid and Neural Tube Defects

Summary

The Food and Drug Administration (FDA) is proposing to revoke a regulation authorizing a health claim on the relationship between folic acid and neural tube defects (NTDs) on the labels and in the labeling of dietary supplements, in response to public comments received on the matter.